Epelsiban Besilate

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameEpelsiban Besilate
Drug Alias Name苯磺酸依派西班epelsibanumEpelsiban Besylate苯磺酸依培西班epelsiban +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxytocin receptor antagonists
TargetsOxytocin receptor
Therapy Area/IndicationsPremature BirthAdenomyosisPremature Ejaculation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPremature BirthAdenomyosisPremature Ejaculation

Other Information

ATC CodeN/A
Related LinksN/A